Skip to main content
Publications
Ko DT, Khan AM , Kotrri G, Austin PC, Wijeysundera HC, Koh M, Chu A, Jackevicius CA, Lawler PR, Tu JV. Eligibility, clinical outcomes, and budget impact of PCSK9 inhibitor adoption: the CANHEART PCSK9 study . J Am Heart Assoc. 2018 Nov 6;7(21):e010007. doi: 10.1161/JAHA.118.010007
Chatzi L, Garcia R , Roumeliotaki T, Basterrechea M, Begiristain H, Iniguez C, Vioque J, Kogevinas M, Sunyer J, INMA study group, RHEA study group. Mediterranean diet adherence during pregnancy and risk of wheeze and eczema in the first year of life: INMA (Spain) and RHEA (Greece) mother–child cohort studies . Br J Nutr. 2013 Dec 14;110(11):2058-68. doi: 10.1017/S0007114513001426
Chatzi L, Mendez M, Garcia R , Roumeliotaki T, Ibarluzea J, Tardon A, Amiano P, Lertxundi A, Iniguez C, Vioque J, Kogevinas M, Sunyer J, INMA and RHEA study groups. Mediterranean diet adherence during pregnancy and fetal growth: INMA (Spain) and RHEA (Greece) mother-child cohort studies . Br J Nutr. 2012 Jan;107(1):135-45. doi: 10.1017/S0007114511002625
Herman WH, Hoerger TJ, Hicks K , Brandle M, Sorensen SW, Zhang P, Engelgau MM, Hamman RF, Marrero DG, Ackermann DT, Ratner RE. Managing people at high risk for diabetes . Ann Intern Med. 2006 Jan 3;144(1):66-7.